AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
PROGNOSTIC VALUE OF BIOMARKERS IN MALIGNANT-MELANOMA
Authors: HERNBERG M TURUNEN JP VONBOGUSLAWSKY K MUHONEN T PYRHONEN S
Citation: M. Hernberg et al., PROGNOSTIC VALUE OF BIOMARKERS IN MALIGNANT-MELANOMA, Melanoma research, 8(3), 1998, pp. 283-291
THE TREATMENT OF METASTATIC UVEAL MELANOMA
Authors: PYRHONEN S
Citation: S. Pyrhonen, THE TREATMENT OF METASTATIC UVEAL MELANOMA, European journal of cancer, 34, 1998, pp. 27-30
RANDOMIZED TRIAL OF IRINOTECAN PLUS SUPPORTIVE CARE VERSUS SUPPORTIVECARE ALONE AFTER FLUOROURACIL FAILURE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: CUNNINGHAM D PYRHONEN S JAMES RD PUNT CJA HICKISH TF HEIKKILA R JOHANNESEN TB STARKHAMMAR H TOPHAM CA AWAD L JACQUES C HERAIT P
Citation: D. Cunningham et al., RANDOMIZED TRIAL OF IRINOTECAN PLUS SUPPORTIVE CARE VERSUS SUPPORTIVECARE ALONE AFTER FLUOROURACIL FAILURE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1413-1418
TUMOR-INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY
Authors: HERNBERG M TURUNEN JP MUHONEN T PYRHONEN S
Citation: M. Hernberg et al., TUMOR-INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY, Journal of immunotherapy, 20(6), 1997, pp. 488-495
ORAL SOURCES OF SEPTICEMIA IN PATIENTS WITH MALIGNANCIES
Authors: MEURMAN JH PYRHONEN S TEERENHOVI L LINDQVIST C
Citation: Jh. Meurman et al., ORAL SOURCES OF SEPTICEMIA IN PATIENTS WITH MALIGNANCIES, Oral Oncology, 33(6), 1997, pp. 389-397
5-YEAR FOLLOW-UP-STUDY OF SALIVA, MUTANS STREPTOCOCCI, LACTOBACILLI AND YEAST COUNTS IN LYMPHOMA PATIENTS
Authors: MEURMAN JH LAINE P LINDQVIST C TEERENHOVI L PYRHONEN S
Citation: Jh. Meurman et al., 5-YEAR FOLLOW-UP-STUDY OF SALIVA, MUTANS STREPTOCOCCI, LACTOBACILLI AND YEAST COUNTS IN LYMPHOMA PATIENTS, Oral Oncology, 33(6), 1997, pp. 439-443
INTERFERON MAINTENANCE THERAPY FOR SMALL-CELL LUNG-CANCER - IMPROVEMENT IN LONG-TERM SURVIVAL
Authors: MATTSON K NIIRANEN A RUOTSALAINEN T MAASILTA P HALME M PYRHONEN S KAJANTI M MANTYLA M TAMMINEN K JEKUNEN A SARNA S CANTELL K
Citation: K. Mattson et al., INTERFERON MAINTENANCE THERAPY FOR SMALL-CELL LUNG-CANCER - IMPROVEMENT IN LONG-TERM SURVIVAL, Journal of interferon & cytokine research, 17(2), 1997, pp. 103-105
5-YEAR FOLLOW-UP OF SALIVA IN PATIENTS TREATED FOR LYMPHOMAS
Authors: MEURMAN JH LAINE P KEINANEN S PYRHONEN S TEERENHOVI L LINDQVIST C
Citation: Jh. Meurman et al., 5-YEAR FOLLOW-UP OF SALIVA IN PATIENTS TREATED FOR LYMPHOMAS, Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 83(4), 1997, pp. 447-452
LOW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES
Authors: VEHMANEN P FRIEDMAN LS EEROLA H MCCLURE M WARD B SARANTAUS L KAINU T SYRJAKOSKI K PYRHONEN S KALLIONIEMI OP MUHONEN T LUCE M FRANK TS NEVANLINNA H
Citation: P. Vehmanen et al., LOW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES, Human molecular genetics, 6(13), 1997, pp. 2309-2315
DNA FLOW-CYTOMETRY AND THE OUTCOME OF CHEMOIMMUNOTHERAPY IN METASTATIC MELANOMA
Authors: HAHKAKEMPPINEN M MUHONEN T NORDLING S PYRHONEN S
Citation: M. Hahkakemppinen et al., DNA FLOW-CYTOMETRY AND THE OUTCOME OF CHEMOIMMUNOTHERAPY IN METASTATIC MELANOMA, Melanoma research, 7(4), 1997, pp. 329-334
CAN THE CD4+ CD8+ RATIO PREDICT THE OUTCOME OF INTERFERON-ALPHA THERAPY FOR RENAL-CELL CARCINOMA/
Authors: HERNBERG M MUHONEN T PYRHONEN S
Citation: M. Hernberg et al., CAN THE CD4+ CD8+ RATIO PREDICT THE OUTCOME OF INTERFERON-ALPHA THERAPY FOR RENAL-CELL CARCINOMA/, Annals of oncology, 8(1), 1997, pp. 71-77
ALTERED FRACTIONATION OF HEMITHORAX IRRADIATION FOR PLEURAL MESOTHELIOMA AND FAILURE PATTERNS AFTER TREATMENT
Authors: HOLSTI LR PYRHONEN S KAJANTI M MANTYLA M MATTSON K MAASILTA P KIVISAARI L
Citation: Lr. Holsti et al., ALTERED FRACTIONATION OF HEMITHORAX IRRADIATION FOR PLEURAL MESOTHELIOMA AND FAILURE PATTERNS AFTER TREATMENT, Acta oncologica, 36(4), 1997, pp. 397-405
BRCA-1 SEQUENCE-ANALYSIS IN WOMEN AT HIGH-RISK FOR SUSCEPTIBILITY MUTATIONS - RISK FACTOR-ANALYSIS AND IMPLICATIONS FOR GENETIC TESTING
Authors: SHATTUCKEIDENS D OLIPHANT A MCCLURE M MCBRIDE C GUPTE J RUBANO T PRUSS D TAVTIGIAN SV TENG DHF ADEY N STAEBELL M GUMPPER K LUNDSTROM R HULICK M KELLY M HOLMEN J LINGENFELTER B MANLEY S FUJIMURA F LUCE M WARD B CANNONALBRIGHT L STEELE L OFFIT K GILEWSKI T NORTON L BROWN K SCHULZ C HAMPEL H SCHLUGER A GIULOTTO E ZOLI W RAVAIOLI A NEVANLINNA H PYRHONEN S ROWLEY P LOADER S OSBORNE MP DALY M TEPLER I WEINSTEIN PL SCALIA JL MICHAELSON R SCOTT RJ RADICE P PIEROTTI MA GARBER JE ISAACS C PESHKIN B LIPPMAN ME DOSIK MH CALIGO MA GREENSTEIN RM PILARSKI R WEBER B BURGEMEISTER R FRANK TS SKOLNICK MH THOMAS A
Citation: D. Shattuckeidens et al., BRCA-1 SEQUENCE-ANALYSIS IN WOMEN AT HIGH-RISK FOR SUSCEPTIBILITY MUTATIONS - RISK FACTOR-ANALYSIS AND IMPLICATIONS FOR GENETIC TESTING, JAMA, the journal of the American Medical Association, 278(15), 1997, pp. 1242-1250
INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA
Authors: VLAYKOVA T JEKUNEN AP KESOMAA M KAIREMO KJA PYRHONEN S WASENIUS VM
Citation: T. Vlaykova et al., INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA, Oncology, 54(2), 1997, pp. 146-152
VASCULARITY AND PROGNOSIS OF METASTATIC MELANOMA
Authors: VLAYKOVA T MUHONEN T HAHKAKEMPPINEN M PYRHONEN S JEKUNEN A
Citation: T. Vlaykova et al., VASCULARITY AND PROGNOSIS OF METASTATIC MELANOMA, International journal of cancer, 74(3), 1997, pp. 326-329
VERRUCOUS CARCINOMA OF THE PENIS - 3 CASES TREATED WITH INTERFERON-ALPHA
Authors: MAICHE AG PYRHONEN S
Citation: Ag. Maiche et S. Pyrhonen, VERRUCOUS CARCINOMA OF THE PENIS - 3 CASES TREATED WITH INTERFERON-ALPHA, British Journal of Urology, 79(3), 1997, pp. 481-483
BREAST-CANCER RISK-ESTIMATION IN FAMILIES WITH HISTORY OF BREAST-CANCER
Authors: MUHONEN T EEROLA H VEHMANEN P NEVANLINNA H AKTAN K BLOMQVIST C KAARIAINEN H PYRHONEN S
Citation: T. Muhonen et al., BREAST-CANCER RISK-ESTIMATION IN FAMILIES WITH HISTORY OF BREAST-CANCER, British Journal of Cancer, 76(9), 1997, pp. 1228-1231
COMPARISON OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A RANDOMIZED DOUBLE-BLIND, THE NORDIC PHASE-III STUDY
Authors: PYRHONEN S VALAVAARA R MODIG H PAWLICKI M PIENKOWSKI T GUNDERSEN S BAUER J WESTMAN G LUNDGREN S BIANCO G MELLA O NILSSON I HIETANEN T HINDY I VUORINEN J HAJBA A
Citation: S. Pyrhonen et al., COMPARISON OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A RANDOMIZED DOUBLE-BLIND, THE NORDIC PHASE-III STUDY, British Journal of Cancer, 76(2), 1997, pp. 270-277
SOMATIC GENETIC AND PHENOTYPIC CHARACTERISTICS OF HEREDITARY BREAST-CANCER
Authors: KAINU T TIRKKONEN M KONONEN J JOHANSSON O LOMAN N OLSSON H SYRJAKOSKI K EEROLA HL HEIKKILA P PYRHONEN S AGNARSSON BA EGILSSON V BARKARDOTTIR R NEVANLINNA H BORG A KALLIONIEMI OP
Citation: T. Kainu et al., SOMATIC GENETIC AND PHENOTYPIC CHARACTERISTICS OF HEREDITARY BREAST-CANCER, American journal of human genetics, 61(4), 1997, pp. 377-377
A LAW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - STRONG EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES
Authors: VEHMANEN P FRIEDMAN LS EEROLA H MCCLURE M WARD B SARANTAUS L KAINU T SYRJAKOSKI K PYRHONEN S KALLIONIEMI OP MUHONEN T LUCE M FRANK TS NEVANLINNA HA
Citation: P. Vehmanen et al., A LAW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - STRONG EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES, American journal of human genetics, 61(4), 1997, pp. 472-472
A LOW PROPORTION OF BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES
Authors: VEHMANEN P FRIEDMAN LS EEROLA H SARANTAUS L PYRHONEN S PONDER BAJ MUHONEN T NEVANLINNA H
Citation: P. Vehmanen et al., A LOW PROPORTION OF BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES, American journal of human genetics, 60(5), 1997, pp. 1050-1058
CHEMOSENSITIVITY OF HUMAN-MELANOMA METASTASES IN MOUSE SUBRENAL CAPSULE ASSAY - CAN IT PREDICT TUMOR RESPONSE TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY IN METASTATIC MELANOMA
Authors: HAHKAKEMPPINEN M MUHONEN T KANGAS L PYRHONEN S
Citation: M. Hahkakemppinen et al., CHEMOSENSITIVITY OF HUMAN-MELANOMA METASTASES IN MOUSE SUBRENAL CAPSULE ASSAY - CAN IT PREDICT TUMOR RESPONSE TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY IN METASTATIC MELANOMA, Melanoma research, 6(3), 1996, pp. 215-221
A PHASE-II TRIAL OF DOCETAXEL IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: SAARINEN A JEKUNEN A HALME M PYRHONEN S TAMMINEN K BOYER R ROUBILLE N MATTSON K
Citation: A. Saarinen et al., A PHASE-II TRIAL OF DOCETAXEL IN ADVANCED NONSMALL CELL LUNG-CANCER, Anti-cancer drugs, 7(8), 1996, pp. 890-892
CYTOKINE THERAPY OF MALIGNANT-MELANOMA
Authors: VILLIKKA K PYRHONEN S
Citation: K. Villikka et S. Pyrhonen, CYTOKINE THERAPY OF MALIGNANT-MELANOMA, Annals of medicine, 28(3), 1996, pp. 227-233
ANTIESTROGENS AND THE REDUCTION IN CIRCULATING CHOLESTEROL - IN REPLY
Authors: GYLLING H PYRHONEN S MAENPAA H MIETTINEN TA MANTYLA E KANGAS L
Citation: H. Gylling et al., ANTIESTROGENS AND THE REDUCTION IN CIRCULATING CHOLESTEROL - IN REPLY, Journal of clinical oncology, 14(8), 1996, pp. 2408-2408
Risultati: 1-25 | 26-50 | 51-58